Hengrui Pharma Shares Rise as Novo Nordisk Signs $2.6 Billion Drug Deal

3-line summary

• Hengrui Pharma shares rose after Novo Nordisk signed a $2.6 billion drug deal with the company, according to an Investing.com report.

This summary is our own processing of the source article; see the source link below for full context.